Featured Research

from universities, journals, and other organizations

Surviving sepsis with LECT2

Date:
December 17, 2012
Source:
Rockefeller University Press
Summary:
Failure to launch an adequate immune response may be at the root of septic shock, according to a new study.

Failure to launch an adequate immune response may be at the root of septic shock, according to a study published Dec. 17 in The Journal of Experimental Medicine.

Bacterial sepsis is a potentially deadly blood infection that results in massive immune activation and inflammation. Sepsis therapies have traditionally focused on quelling this exaggerated inflammatory response. But a recent study challenged this approach by showing that patients with sepsis had abnormally low levels of an inflammatory protein called LECT2.

The new study by Jiong Chen and colleagues at Ningbo University in China shows that low LECT2 levels are indeed detrimental. Injecting LECT2 into septic mice promoted bacterial clearance by immune cells called macrophages and increased their production of survival-promoting factors. If these findings hold true in humans, boosting immunity with LECT2 may be protective by helping clear the infection.


Story Source:

The above story is based on materials provided by Rockefeller University Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. X.-J. Lu, J. Chen, C.-H. Yu, Y.-H. Shi, Y.-Q. He, R.-C. Zhang, Z.-A. Huang, J.-N. Lv, S. Zhang, L. Xu. LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor. Journal of Experimental Medicine, 2012; DOI: 10.1084/jem.20121466

Cite This Page:

Rockefeller University Press. "Surviving sepsis with LECT2." ScienceDaily. ScienceDaily, 17 December 2012. <www.sciencedaily.com/releases/2012/12/121217121609.htm>.
Rockefeller University Press. (2012, December 17). Surviving sepsis with LECT2. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/12/121217121609.htm
Rockefeller University Press. "Surviving sepsis with LECT2." ScienceDaily. www.sciencedaily.com/releases/2012/12/121217121609.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins